SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bionano Genomics, Inc. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Tuesday, 3/5/24, at 5:26pm ET   ·   For:  12/31/23   ·   Accession #:  1411690-24-13   ·   File #:  1-38613

Previous ‘10-K’:  ‘10-K’ on 3/9/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   24 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/05/24  Bionano Genomics, Inc.            10-K       12/31/23  105:13M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.40M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     31K 
 3: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     42K 
 4: EX-22.1     Published Report re: Matters Submitted to a Vote    HTML     29K 
                of Security Holders                                              
 5: EX-23.1     Consent of Expert or Counsel                        HTML     28K 
10: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     51K 
                Awarded Compensation                                             
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
16: R1          Cover                                               HTML     96K 
17: R2          Audit Information                                   HTML     34K 
18: R3          Consolidated Balance Sheets                         HTML    150K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     49K 
20: R5          Consolidated Statements of Operations               HTML    110K 
21: R6          Consolidated Statements of Comprehensive Loss       HTML     55K 
22: R7          Consolidated Statements of Stockholders? Equity     HTML     95K 
                (Deficit)                                                        
23: R8          Consolidated Statements of Cash Flows               HTML    177K 
24: R9          Organization and Operations                         HTML     37K 
25: R10         Summary of Significant Accounting Policies          HTML    127K 
26: R11         Revenue from Contracts with Customers               HTML     55K 
27: R12         Investments and Fair Value Measurements             HTML    214K 
28: R13         Prepaid Expenses and Other Current Assets           HTML     41K 
29: R14         Property and Equipment, Net                         HTML     41K 
30: R15         Intangible Assets, Net                              HTML     55K 
31: R16         Accrued Expenses                                    HTML     41K 
32: R17         High Trail Agreement                                HTML     64K 
33: R18         Stockholders? Equity and Stock-Based Compensation   HTML    112K 
34: R19         Commitments and Contingencies                       HTML     81K 
35: R20         Income Taxes                                        HTML     97K 
36: R21         Employee Benefits                                   HTML     31K 
37: R22         Acquisitions                                        HTML     58K 
38: R23         Related Party Transactions                          HTML     34K 
39: R24         Pay vs Performance Disclosure                       HTML     41K 
40: R25         Insider Trading Arrangements                        HTML     35K 
41: R26         Summary of Significant Accounting Policies          HTML    161K 
                (Policies)                                                       
42: R27         Summary of Significant Accounting Policies          HTML     78K 
                (Tables)                                                         
43: R28         Revenue from Contracts with Customers (Tables)      HTML     52K 
44: R29         Investments and Fair Value Measurements (Tables)    HTML    210K 
45: R30         Prepaid Expenses and Other Current Assets (Tables)  HTML     42K 
46: R31         Property and Equipment, Net (Tables)                HTML     40K 
47: R32         Intangible Assets, Net (Tables)                     HTML     56K 
48: R33         Accrued Expenses (Tables)                           HTML     41K 
49: R34         High Trail Agreement (Tables)                       HTML     40K 
50: R35         Stockholders? Equity and Stock-Based Compensation   HTML     96K 
                (Tables)                                                         
51: R36         Commitments and Contingencies (Tables)              HTML     88K 
52: R37         Income Taxes (Tables)                               HTML     96K 
53: R38         Acquisitions (Tables)                               HTML     59K 
54: R39         Organization and Operations (Details)               HTML     72K 
55: R40         Summary of Significant Accounting Policies -        HTML    101K 
                Additional Information (Details)                                 
56: R41         Summary of Significant Accounting Policies -        HTML     36K 
                Accounts Receivable (Details)                                    
57: R42         Summary of Significant Accounting Policies -        HTML     36K 
                Changes of Allowance for Credit Losses (Details)                 
58: R43         Summary of Significant Accounting Policies -        HTML     42K 
                Inventories (Details)                                            
59: R44         Summary of Significant Accounting Policies -        HTML     41K 
                Goodwill (Details)                                               
60: R45         Summary of Significant Accounting Policies -        HTML     44K 
                Potentially Dilutive Securities not Included in                  
                Calculation of Diluted Net Loss Per Share                        
                Attributable to Common Stockholders (Details)                    
61: R46         Revenue from Contracts with Customers (Details)     HTML     67K 
62: R47         Investments and Fair Value Measurements -           HTML    104K 
                Financial Assets and Liabilities (Details)                       
63: R48         Investments and Fair Value Measurements -           HTML     91K 
                Additional Information (Details)                                 
64: R49         Investments and Fair Value Measurements -           HTML     63K 
                Estimated Fair Value Assumption (Details)                        
65: R50         Investments and Fair Value Measurements - Level 3   HTML     58K 
                Measurement (Details)                                            
66: R51         Investments and Fair Value Measurements -           HTML     85K 
                Amortized Cost and Unrealized Gains (Losses)                     
                (Details)                                                        
67: R52         Investments and Fair Value Measurements -           HTML     71K 
                Unrealized Losses Positions (Details)                            
68: R53         Prepaid Expenses and Other Current Assets           HTML     48K 
                (Details)                                                        
69: R54         Property and Equipment, Net - Property and          HTML     46K 
                Equipment, net (Details)                                         
70: R55         Property and Equipment, Net - Additional            HTML     33K 
                Information (Details)                                            
71: R56         Intangible Assets, Net - Intangible Assets          HTML     44K 
                (Details)                                                        
72: R57         Intangible Assets, Net - Additional Information     HTML     47K 
                (Details)                                                        
73: R58         Intangible Assets, Net - Future Amortization of     HTML     44K 
                Intangible Assets (Details)                                      
74: R59         Accrued Expenses (Details)                          HTML     48K 
75: R60         High Trail Agreement - Additional Information       HTML    163K 
                (Details)                                                        
76: R61         High Trail Agreement - Schedule of Convertible      HTML     43K 
                Debt (Details)                                                   
77: R62         High Trail Agreement - Schedule of Future           HTML     44K 
                Aggregate Redemption (Details)                                   
78: R63         Stockholders? Equity and Stock-Based Compensation   HTML    228K 
                - Additional Information (Details)                               
79: R64         Stockholders? Equity and Stock-Based Compensation   HTML     57K 
                - Warrant Activity (Details)                                     
80: R65         Stockholders? Equity and Stock-Based Compensation   HTML     73K 
                - Stock Option Activity (Details)                                
81: R66         Stockholders? Equity and Stock-Based Compensation   HTML     60K 
                - Restricted Stock and Performance Stock Activity                
                (Details)                                                        
82: R67         Stockholders? Equity and Stock-Based Compensation   HTML     49K 
                - Recognized Stock-Based Compensation Expense                    
                (Details)                                                        
83: R68         Stockholders? Equity and Stock-Based Compensation   HTML     38K 
                - Assumptions (Details)                                          
84: R69         Commitments and Contingencies - Additional          HTML     80K 
                Information (Details)                                            
85: R70         Commitments and Contingencies - Supplemental        HTML     52K 
                Information (Details)                                            
86: R71         Commitments and Contingencies - Lease Cost          HTML     48K 
                (Details)                                                        
87: R72         Commitments and Contingencies - Undiscounted        HTML     77K 
                Future Non-Cancellable Lease Payments Under Leases               
                (Details)                                                        
88: R73         Income Taxes - Domestic and Foreign Components of   HTML     38K 
                Income (Loss) (Details)                                          
89: R74         Income Taxes - Provision for Domestic and Foreign   HTML     56K 
                Income Taxes (Details)                                           
90: R75         Income Taxes - Effective Income Tax Rate            HTML     56K 
                Reconciliation (Details)                                         
91: R76         Income Taxes - Deferred Tax Assets (Details)        HTML     54K 
92: R77         Income Taxes - Additional Information (Details)     HTML     71K 
93: R78         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     38K 
94: R79         Employee Benefits (Details)                         HTML     30K 
95: R80         Acquisitions - Additional Information (Details)     HTML     47K 
96: R81         Acquisitions - Acquisition Purchase Price           HTML     39K 
                (Details)                                                        
97: R82         Acquisitions - Fair Value of Tangible and           HTML     64K 
                Identifiable Assets Acquired and Liabilities                     
                Assumed (Details)                                                
98: R83         Acquisitions - Identifiable Intangible Assets       HTML     39K 
                (Details)                                                        
99: R84         Acquisitions - Pro Forma Information (Details)      HTML     38K 
100: R85         Related Party Transactions (Details)                HTML     34K  
102: XML         IDEA XML File -- Filing Summary                      XML    188K  
105: XML         XBRL Instance -- bngo-20231231_htm                   XML   2.55M  
101: EXCEL       IDEA Workbook of Financial Report Info              XLSX    220K  
12: EX-101.CAL  XBRL Calculations -- bngo-20231231_cal               XML    346K 
13: EX-101.DEF  XBRL Definitions -- bngo-20231231_def                XML    979K 
14: EX-101.LAB  XBRL Labels -- bngo-20231231_lab                     XML   2.50M 
15: EX-101.PRE  XBRL Presentations -- bngo-20231231_pre              XML   1.65M 
11: EX-101.SCH  XBRL Schema -- bngo-20231231                         XSD    244K 
103: JSON        XBRL Instance as JSON Data -- MetaLinks              710±  1.08M  
104: ZIP         XBRL Zipped Folder -- 0001411690-24-000013-xbrl      Zip   1.03M  


‘EX-97.1’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 97.1
Bionano Genomics, Inc.
Incentive Compensation Recoupment Policy
1.Introduction
The Board of Directors (the “Board”) of Bionano Genomics, Inc., a Delaware corporation (the “Company”), has determined that it is in the best interests of the Company and its stockholders to adopt this Incentive Compensation Recoupment Policy (this “Policy”) providing for the Company’s recoupment of Recoverable Incentive Compensation that is received by Covered Officers of the Company under certain circumstances. Certain capitalized terms used in this Policy have the meanings given to such terms in Section 3 below.
This Policy is designed to comply with, and shall be interpreted to be consistent with, Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder (“Rule 10D-1”) and Nasdaq Listing Rule 5608 (the “Listing Standards”).
2.Effective Date
This Policy shall apply to all Incentive Compensation that is received by a Covered Officer on or after October 2, 2023 (the “Effective Date”). Incentive Compensation is deemed “received” in the Company’s fiscal period in which the Financial Reporting Measure specified in the Incentive Compensation award is attained, even if the payment or grant of such Incentive Compensation occurs after the end of that period.
3.Definitions
Accounting Restatement” means an accounting restatement that the Company is required to prepare due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
Accounting Restatement Date” means the earlier to occur of (a) the date that the Board, a committee of the Board authorized to take such action, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (b) the date that a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.
Administrator” means the Compensation Committee or, in the absence of such committee, the Board.
Code” means the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.
Compensation Committee” means the Compensation Committee of the Board.
Covered Officer” means each current and former Executive Officer.
Exchange” means the Nasdaq Stock Market.
Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.
Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs
292058696 v1



similar policy-making functions for the Company. Executive officers of the Company’s parent(s) or subsidiaries are deemed executive officers of the Company if they perform such policy-making functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. Identification of an executive officer for purposes of this Policy would include at a minimum executive officers identified pursuant to Item 401(b) of Regulation S-K promulgated under the Exchange Act.
Financial Reporting Measures” means measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, including Company stock price and total stockholder return (“TSR”). A measure need not be presented in the Company’s financial statements or included in a filing with the SEC in order to be a Financial Reporting Measure.
Incentive Compensation” means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure.
Lookback Period” means the three completed fiscal years immediately preceding the Accounting Restatement Date, as well as any transition period (resulting from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years (except that a transition period of at least nine months shall count as a completed fiscal year). Notwithstanding the foregoing, the Lookback Period shall not include fiscal years completed prior to the Effective Date.
Recoverable Incentive Compensation” means Incentive Compensation received by a Covered Officer during the Lookback Period that exceeds the amount of Incentive Compensation that would have been received had such amount been determined based on the Accounting Restatement, computed without regard to any taxes paid (i.e., on a gross basis without regard to tax withholdings and other deductions). For any compensation plans or programs that take into account Incentive Compensation, the amount of Recoverable Incentive Compensation for purposes of this Policy shall include, without limitation, the amount contributed to any notional account based on Recoverable Incentive Compensation and any earnings to date on that notional amount. For any Incentive Compensation that is based on stock price or TSR, where the Recoverable Incentive Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the Administrator will determine the amount of Recoverable Incentive Compensation based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or TSR upon which the Incentive Compensation was received. The Company shall maintain documentation of the determination of that reasonable estimate and provide such documentation to the Exchange in accordance with the Listing Standards.
SEC” means the U.S. Securities and Exchange Commission.
4.Recoupment
(a)Applicability of Policy. This Policy applies to Incentive Compensation received by a Covered Officer (i) after beginning services as an Executive Officer, (ii) who served as an Executive Officer at any time during the performance period for such Incentive Compensation, (iii) while the Company had a class of securities listed on a national securities exchange or a national securities association, and (iv) during the Lookback Period.
(b)Recoupment Generally. Pursuant to the provisions of this Policy, if there is an Accounting Restatement, the Company must reasonably promptly recoup the full amount of the Recoverable Incentive Compensation, unless the conditions of one or more subsections of Section 4(c) of this Policy are met and the Compensation Committee, or, if such committee does not consist solely of independent directors, a majority of the independent directors serving on the Board, has made a determination that recoupment would be impracticable. Recoupment is required regardless of whether the Covered Officer engaged in any misconduct and regardless of fault, and the Company’s obligation to recoup Recoverable Incentive Compensation is not dependent on whether or when any restated financial statements are filed.
(c)Impracticability of Recovery. Recoupment may be determined to be impracticable if, and only if:
2
292058696 v1



(i)the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount of the applicable Recoverable Incentive Compensation; provided that, before concluding that it would be impracticable to recover any amount of Recoverable Incentive Compensation based on expense of enforcement, the Company shall make a reasonable attempt to recover such Recoverable Incentive Compensation, document such reasonable attempt(s) to recover, and provide that documentation to the Exchange in accordance with the Listing Standards; or
(ii)recoupment of the applicable Recoverable Incentive Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Code Section 401(a)(13) or Code Section 411(a) and regulations thereunder.
(d)Sources of Recoupment. To the extent permitted by applicable law, the Administrator shall, in its sole discretion, determine the timing and method for recouping Recoverable Incentive Compensation hereunder, provided that such recoupment is undertaken reasonably promptly. The Administrator may, in its discretion, seek recoupment from a Covered Officer from any of the following sources or a combination thereof, whether the applicable compensation was approved, awarded, granted, payable or paid to the Covered Officer prior to, on or after the Effective Date: (i) direct repayment of Recoverable Incentive Compensation previously paid to the Covered Officer; (ii) cancelling prior cash or equity-based awards (whether vested or unvested and whether paid or unpaid); (iii) cancelling or offsetting against any planned future cash or equity-based awards; (iv) forfeiture of deferred compensation, subject to compliance with Code Section 409A; and (v) any other method authorized by applicable law or contract. Subject to compliance with any applicable law, the Administrator may effectuate recoupment under this Policy from any amount otherwise payable to the Covered Officer, including amounts payable to such individual under any otherwise applicable Company plan or program, e.g., base salary, bonuses or commissions and compensation previously deferred by the Covered Officer. The Administrator need not utilize the same method of recovery for all Covered Officers or with respect to all types of Recoverable Incentive Compensation.
(e)No Indemnification of Covered Officers. Notwithstanding any indemnification agreement, applicable insurance policy or any other agreement or provision of the Company’s certificate of incorporation or bylaws to the contrary, no Covered Officer shall be entitled to indemnification or advancement of expenses in connection with any enforcement of this Policy by the Company, including paying or reimbursing such Covered Officer for insurance premiums to cover potential obligations to the Company under this Policy.
(f)Indemnification of Administrator. Any members of the Administrator, and any other members of the Board who assist in the administration of this Policy, shall not be personally liable for any action, determination or interpretation made with respect to this Policy and shall be indemnified by the Company to the fullest extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board under applicable law or Company policy.
(g)No “Good Reason” for Covered Officers. Any action by the Company to recoup or any recoupment of Recoverable Incentive Compensation under this Policy from a Covered Officer shall not be deemed (i) “good reason” for resignation or to serve as a basis for a claim of constructive termination under any benefits or compensation arrangement applicable to such Covered Officer, or (ii) to constitute a breach of a contract or other arrangement to which such Covered Officer is party.
5.Administration
Except as specifically set forth herein, this Policy shall be administered by the Administrator. The Administrator shall have full and final authority to make any and all determinations required under this Policy. Any determination by the Administrator with respect to this Policy shall be final, conclusive and binding on all interested parties and need not be uniform with respect to each individual covered by this Policy. In carrying out the administration of this Policy, the Administrator is authorized and directed to consult with the full Board or such other committees of the Board as may be necessary or appropriate as to matters within the scope of such other committee’s responsibility and authority. Subject to applicable
3
292058696 v1



law, the Administrator may authorize and empower any officer or employee of the Company to take any and all actions that the Administrator, in its sole discretion, deems necessary or appropriate to carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee).
6.Severability
If any provision of this Policy or the application of any such provision to a Covered Officer shall be adjudicated to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Policy, and the invalid, illegal or unenforceable provisions shall be deemed amended to the minimum extent necessary to render any such provision or application enforceable.
7.No Impairment of Other Remedies
Nothing contained in this Policy, and no recoupment or recovery as contemplated herein, shall limit any claims, damages or other legal remedies the Company or any of its affiliates may have against a Covered Officer arising out of or resulting from any actions or omissions by the Covered Officer. This Policy does not preclude the Company from taking any other action to enforce a Covered Officer’s obligations to the Company, including, without limitation, termination of employment and/or institution of civil proceedings. This Policy is in addition to the requirements of Section 304 of the Sarbanes-Oxley Act of 2002 (“SOX 304”) that are applicable to the Company’s Chief Executive Officer and Chief Financial Officer and to any other compensation recoupment policy and/or similar provisions in any employment, equity plan, equity award, or other individual agreement, to which the Company is a party or which the Company has adopted or may adopt and maintain from time to time; provided, however, that compensation recouped pursuant to this Policy shall not be duplicative of compensation recouped pursuant to SOX 304 or any such compensation recoupment policy and/or similar provisions in any such employment, equity plan, equity award, or other individual agreement except as may be required by law.
8.Amendment; Termination
The Administrator may amend, terminate or replace this Policy or any portion of this Policy at any time and from time to time in its sole discretion. The Administrator shall amend this Policy as it deems necessary to comply with applicable law or any Listing Standard.
9.Successors
This Policy shall be binding and enforceable against all Covered Officers and, to the extent required by Rule 10D-1 and/or the applicable Listing Standards, their beneficiaries, heirs, executors, administrators or other legal representatives.
10.    Required Filings
    The Company shall make any disclosures and filings with respect to this Policy that are required by law, including as required by the SEC.
*    *    *    *    *
4
292058696 v1



Bionano Genomics, Inc.
Incentive Compensation Recoupment Policy
Form of Executive Acknowledgment

I, the undersigned, agree and acknowledge that I am bound by, and subject to, the Bionano Genomics, Inc. Incentive Compensation Recoupment Policy, as may be amended, restated, supplemented or otherwise modified from time to time (the “Policy”). In the event of any inconsistency between the Policy and the terms of any employment agreement, offer letter or other individual agreement with Bionano Genomics, Inc. (the “Company”) to which I am a party, or the terms of any compensation plan, program or agreement, whether or not written, under which any compensation has been granted, awarded, earned or paid to me, the terms of the Policy shall govern.
In the event that the Administrator (as defined in the Policy) determines that any compensation granted, awarded, earned or paid to me must be forfeited or reimbursed to the Company pursuant to the Policy, I will promptly take any action necessary to effectuate such forfeiture and/or reimbursement. I further agree and acknowledge that I am not entitled to indemnification, and hereby waive any right to advancement of expenses, in connection with any enforcement of the Policy by the Company.

Agreed and Acknowledged:

    
Name:     
Title:     
Date:     


292058696 v1


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/5/248-K
For Period end:12/31/23
10/2/23
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/08/24  Bionano Genomics, Inc.            424B5                  1:711K                                   Broadridge Fin’l So… Inc


23 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Bionano Genomics, Inc.            8-K:1,7,9   2/27/24   13:252K                                   Broadridge Fin’l So… Inc
11/08/23  Bionano Genomics, Inc.            10-Q        9/30/23   71:8.4M
10/11/23  Bionano Genomics, Inc.            8-K:1,2,3,710/09/23   16:1.4M                                   Broadridge Fin’l So… Inc
 8/04/23  Bionano Genomics, Inc.            8-K:3,5,9   8/04/23   13:239K                                   Broadridge Fin’l So… Inc
 5/09/23  Bionano Genomics, Inc.            10-Q        3/31/23   67:7.4M
 4/14/23  Bionano Genomics, Inc.            8-K:1,3,5,9 4/13/23   14:325K                                   Broadridge Fin’l So… Inc
 3/09/23  Bionano Genomics, Inc.            10-K       12/31/22  104:13M
11/28/22  Bionano Genomics, Inc.            8-K:1,7,8,911/23/22   14:1.5M                                   Broadridge Fin’l So… Inc
 3/01/22  Bionano Genomics, Inc.            10-K       12/31/21  104:17M
10/19/21  Bionano Genomics, Inc.            8-K:2,9    10/18/21   12:1.2M                                   Broadridge Fin’l So… Inc
 8/04/21  Bionano Genomics, Inc.            10-Q        6/30/21   57:5.5M
 3/24/21  Bionano Genomics, Inc.            8-K:8,9     3/23/21   13:581K                                   Broadridge Fin’l So… Inc
 3/23/21  Bionano Genomics, Inc.            10-K       12/31/20   88:9.4M
11/13/20  Bionano Genomics, Inc.            10-Q        9/30/20   60:6.4M
 8/24/20  Bionano Genomics, Inc.            8-K:1,2,3,8 8/20/20    5:1.8M                                   Broadridge Fin’l So… Inc
 8/14/20  Bionano Genomics, Inc.            S-8         8/14/20    4:228K                                   Broadridge Fin’l So… Inc
 3/24/20  Bionano Genomics, Inc.            S-1/A                  6:1.2M                                   Broadridge Fin’l So… Inc
 9/18/19  Bionano Genomics, Inc.            S-1                    5:1.1M                                   Broadridge Fin’l So… Inc
 8/28/18  Bionano Genomics, Inc.            S-8         8/28/18    5:273K                                   Donnelley … Solutions/FA
 8/24/18  Bionano Genomics, Inc.            8-K:5,9     8/23/18    3:211K                                   Donnelley … Solutions/FA
 7/17/18  Bionano Genomics, Inc.            S-1/A                 13:4.3M                                   Donnelley … Solutions/FA
 7/13/18  Bionano Genomics, Inc.            S-1/A                  7:2.7M                                   Donnelley … Solutions/FA
 6/28/18  Bionano Genomics, Inc.            S-1                   43:9.3M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001411690-24-000013   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 5:19:19.3pm ET